UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) October 10, 2014
Sanomedics International Holdings, Inc. |
(Exact name of registrant as specified in its charter) |
Delaware | | 000-54167 | | 27-3320809 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (IRS Employer Identification No.) |
444 Brickell Avenue, Suite 415, Miami, Florida | | 33131 |
(Address of principal executive offices) | | (Zip Code) |
Registrant's telephone number, including area code (305) 433-7814
not applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
Sanomedics International Holdings, Inc. (the “Company”) is furnishing herewith two (2) press releases issued on October 10, 2014 and October 14, 2014, as Exhibit 99.1, which is included herein. The press releases were issued to report two recent television interviews with our President covering the supply of our Thermomedics Division Caregiver ® TouchFree Clinical Thermometers to help in the fight against Ebola virus at the nation’s airports.
Item 9.01 Financial Statements and Exhibits
(c) Exhibits
| Exhibit 99.1 | | Press Releases of Sanomedics International Holdings, Inc. dated October 10, 2014 and October 14, 2014. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | Sanomedics International Holdings, Inc. | |
| | | |
Date: October 17, 2014 | By: | /s/ David C. Langle | |
| | | David C. Langle, Chief Financial Officer | |
3
